Home › Compare › NUGX vs DIVO

NUGX vs DIVO: Dividend Comparison 2026

NUGX yields 2000000.00% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NUGX wins by $4.879226400974806e+39M in total portfolio value
10 years
NUGX
NUGX
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full NUGX calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — NUGX vs DIVO

📍 NUGX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUGXDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUGX + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NUGX pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUGX
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, NUGX beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUGX + DIVO for your $10,000?

NUGX: 50%DIVO: 50%
100% DIVO50/50100% NUGX
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUGX buys
0
DIVO buys
0
No recent congressional trades found for NUGX or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUGXDIVO
Forward yield2000000.00% ✓6.49%
Annual dividend / share$2.00$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$30.7K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$981.68
Total dividends collected$4.879195005460081e+39M$8.2K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NUGX vs DIVO ($10,000, DRIP)

YearNUGX PortfolioNUGX Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,349$649.42+$200.00M → NUGX
2$3,738,731,768,458$3,738,517,757,009.35$12,833$688.83+$3738731.76M → NUGX
3$65,315,062,866,930,490$65,311,062,423,938,240.00$14,459$727.90+$65315062866.92M → NUGX
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$16,238$766.49+$1066400830062625.00M → NUGX
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$18,179$804.47+$16272182796453826560.00M → NUGX
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$20,293$841.71+$2.3205424011366188e+23M → NUGX
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$22,591$878.14+$3.0927990661046884e+27M → NUGX
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$25,087$913.65+$3.8524105697352695e+31M → NUGX
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$27,791$948.18+$4.484688260147987e+35M → NUGX
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$30,718$981.68+$4.879226400974806e+39M → NUGX

NUGX vs DIVO: Complete Analysis 2026

NUGX — Stock

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.

Full NUGX Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this NUGX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUGX vs SCHDNUGX vs JEPINUGX vs ONUGX vs KONUGX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.